Achieve life sciences announces last subject last visit completed in phase 2 orca-v1 trial of cytisinicline for e-cigarette cessation

Topline data expected in 2q 2023 topline data expected in 2q 2023

ACHV Ratings Summary

ACHV Quant Ranking